COMMUNIQUÉS West-GlobeNewswire

Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère
20/09/2019
Le CHMP recommande l’approbation de Dupixent ® (dupilumab) dans le traitement de la polypose nasosinusienne sévère Paris et Tarrytown (New York) – Le 20 septembre 2019 – Le Comité des médicaments à usage humain (CHMP) [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/09/2019
SAN JUAN CAPISTRANO, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, [...]
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
20/09/2019
SAN FRANCISCO and TOKYO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (Nasdaq: FGEN, Interim CEO: James A. Schoeneck, “FibroGen”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “ [...]
FDA approves cobas Babesia, Roche’s first whole blood test for donor screening
20/09/2019
Roche is dedicated to helping save patients’ lives by delivering state-of-the-art solutions to aid in the protection of the global blood supply from infectious diseases If undetected, Babesia infection can be fatal in [...]
IBA subsidiary, Normandy Hadrontherapy, launches development of carbon therapy system in Normandy, France
20/09/2019
Louvain-La-Neuve, Belgium, 20 September 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the launch of the [...]
Normandy Hadrontherapy, filiale d'IBA, lance le développement d'un système de traitement par carbone en Normandie, en France
20/09/2019
Louvain-La-Neuve, Belgique, 20 septembre 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce le lancement aujourd'hui du [...]
InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering
20/09/2019
TEL AVIV, Israel, Sept. 19, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, [...]
XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)
20/09/2019
● TMX-049 Results Show Beneficial Decrease of Urinary Albumin in T2DN ● CALGARY, Alberta, Sept. 19, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a [...]
Psychemedics Corporation Announces New Brazilian Distribution Agreement
19/09/2019
ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with Toxicologia [...]
CV Sciences, Inc. Announces Plans to File Request For Continued Examination of Its US Patent Application
19/09/2019
SAN DIEGO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today [...]
Align Technology Announces Global Distribution Agreement With Zimmer Biomet Dental For Itero Element® Intraoral Scanners
19/09/2019
Partners with Global Implant and Restorative Dentistry Leader to Increase Penetration of iTero Scanners SAN JOSE, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced a global [...]
Globus Medical Showcases Latest Innovations at NASS 2019
19/09/2019
Technologies featured include Single Position Lateral Surgery driven by ExcelsiusGPS® Interbody Solutions AUDUBON, Pa., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal [...]
Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes
19/09/2019
NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients [...]
Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research
19/09/2019
Data reinforce the scientific evidence supporting the potential treatment of chronic pruritic diseases through OSMRβ inhibition HAMILTON, Bermuda, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq [...]
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
19/09/2019
TUCSON, Ariz., Sept. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it intends to offer and [...]
Galapagos increases share capital through warrant exercises
19/09/2019
Mechelen, Belgium; 19 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 301,745 new [...]
Transparency notification
19/09/2019
Mechelen, Belgium; 19 september 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Sands Capital Management, LLC . Pursuant to Belgian [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
19/09/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
19/09/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Pages